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Abstract 
In this work, we expanded and updated a genome-scale metabolic model of Streptomyces clavuligerus. The model 
includes 1021 genes and 1494 biochemical reactions; genome-reaction information was curated and new features 
related to clavam metabolism and to the biomass synthesis equation were incorporated. The model was validated using 
experimental data from literature and simulations were performed to predict cellular growth and clavulanic acid 
biosynthesis. Flux Balance Analysis (FBA) showed that limiting concentrations of phosphate and an excess of 
ammonia accumulation are unfavorable for growth and clavulanic acid biosynthesis. The evaluation of different 
objective functions for FBA showed that maximization of ATP yields the best predictions for cellular behaviour in 
continuous cultures, while the maximization of growth rate provides better predictions for batch cultures. Through 
gene essentiality analysis, 130 essential genes were found using a limited in silico media, while 100 essential genes 
were identified in amino acid supplemented media. Finally, a strain design was carried out to identify candidate genes 
to be overexpressed or knocked-out so as to maximize antibiotic biosynthesis. Interestingly, potential metabolic 
engineering targets, identified in this study, have not been tested experimentally. 
Keywords Genome-scale metabolic reconstruction, Flux balance analysis, Streptomyces clavuligerus, strain 
improvement, clavulanic acid.  
Introduction  
Streptomyces clavuligerus is a gram-positive bacterium, widely used in the production of clavulanic acid (CA), 
Cephamycin C (CephC) and 5S clavam compounds with antifungal and antitumor activities. CA is a β-lactamase 
inhibitor clinically used in combination with β-lactam antibiotics to treat infections caused by β-lactamase-producing 
bacteria [1].  
The biosynthetic pathway leading to CA starts with the condensation of the C3 precursor glyceraldehyde-3-phosphate 
and the C5 amino precursor L-arginine, to form N2-(2-carboxyethyl) arginine, a reaction catalyzed by 
carboxyethylarginine synthase (CeaS2). Further cyclization, hydroxylation and hydrolysis reactions produce 
clavaminic acid [2,3]; these so-called early steps end by the action of clavaminate synthase (Cas): first, proclavaminic 
acid undergoes cyclization to produce dihydroclavaminic acid, which is subsequently desaturated to yield clavaminic 
acid [3]. In S. clavuligerus, the biosynthetic pathway leading to CA and 5S clavams is partially shared up to the 
clavaminic acid intermediate; the early steps are well characterised, but little is known about the reactions beyond 
clavaminic acid leading to CA or 5S clavams. In these late steps, N-glycyl-clavaminic acid synthetase (gcas) converts 
clavaminic acid into N-glycyl-clavaminic acid, but details of the reactions involved are still unknown. Finally, 
clavaldehyde dehydrogenase (cad) reduces clavaldehyde to form CA; both clavaldehyde and CA share the 3R, 5R 
stereochemistry associated with its inhibitory activity [4]. The genes involved in CA and 5S clavam biosynthesis are 
located in three separated locations within the S. clavuligerus chromosome (secondary biosynthetic clusters). The CA 
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cluster is located next to the CephC gene cluster; the CA-CephC-supercluster and clavam cluster both lie on the 
chromosome, whereas the paralog gene cluster is located in the plasmid pSCL4 [5].  
In view of the clinical and industrial importance of CA, the biosynthetic pathway, the associated gene cluster(s) and 
related regulatory mechanisms that control its production, have been topics of continuous research. S. clavuligerus 
also has a particular response system to nutrient limiting conditions, linked to morphological differentiation and the 
onset of secondary metabolism [2]. These unclear aspects of S. clavuligerus metabolism reveal the need of using 
systemic methodologies that enable a holistic view of CA biosynthesis and accumulation under diverse environmental 
perturbations, so as to capture and eventually understand the genotype-phenotype relationship.  
In order to improve the overall understanding of the metabolic capabilities of microorganisms, a systems biology 
approach, combining experimental and mathematical tools, has been established. Genome scale metabolic models 
(GSMM) have been developed so as to bridge the gap between genome-derived biochemical information and 
metabolic phenotypes in a suitable manner, thus providing a solid interpretative framework for experimental data 
related to metabolic states, and enabling simple in silico experiments considering whole-cell metabolism. The basis 
of a GSMM lies in the functional annotation of the genes, including biosynthetic gene clusters of secondary 
metabolites that, when connected to the biochemical reactions catalyzed by the corresponding enzymes, provide a 
complete summary of the metabolic capabilities of the organism. Since parts of these biosynthetic gene clusters have 
not been fully characterized, GSMM – based simulations, along with bioinformatics tools and experimental data, 
might contribute to further identify their biological function.  
Moreover, GSMMs simulate the operation of the metabolism in response to diverse perturbations, thus contributing 
to decipher potential interactions among metabolic, regulatory and signaling networks in a holistic manner. 
Investigating different in silico metabolic scenarios might facilitate the identification of better nutrient and 
environmental culture conditions for enhanced secondary metabolite production. Several actinomycete GSMMs are 
currently available for S. coelicolor [6], and S. lividans [7]; for S. clavuligerus, Medema et al. [8] presented a GSMM 
describing secondary metabolite production [8]. 
In this work, a reconstructed and updated GSMM was built and used to represent the S. clavuligerus metabolic activity. 
The resulting model was improved by curation of the genome-reaction information, and by adding reactions related 
with clavam metabolism and an updated biomass equation. By simulating different metabolic scenarios, the model 
allowed us to identify potential metabolic targets that might be modified by genetic engineering techniques so as to 
obtain overproducer strains.  
Materials and methods 
Genome-scale metabolic model reconstruction and refinement 
The genome-scale stoichiometric model of S. clavuligerus [8] (kindly provided by Prof Marnix Medema, Wageningen 
University, The Netherlands) and a model for the phylogenetically close organism S. coelicolor A (3), for which 
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genome scale reconstruction information is available [6], were utilized as base models to generate the so called 
iLT1021 model. Besides, a genome scale reconstruction was performed as a parallel model to search for functions that 
might not be included in the base models; for this, the genome of S. clavuligerus ATCC 27064 (accession number 
CM000913.1- CM000914.1) [9], and the Model SEED genome-scale metabolic reconstruction pipeline [10], were 
used. The parallel draft reconstruction had false and missing reactions due to wrong or incomplete annotations [11]; 
hence, it was compared step by step with genome annotations deposited in databases such as StrepDB 
(http://strepdb.streptomyces.org.uk), BioCyc [12], PATRIC [13], and Kyoto Encyclopedia of Genes and Genomes 
(KEGG) [14]; this enabled us to build a complete list of reactions and the corresponding Gene-Protein-Reaction (GPR) 
associations, a very important step for further in silico gene deletion studies. 
The iLT1021 model was converted to SBML format to be fully compatible with COBRA Toolbox [11] and other FBA 
tools like SurreyFBA [15]. The COBRA Toolbox was used to run and refine the model; gaps in the model were then 
identified using the steady-state model and constraint consistency checker (MC3) for biochemical networks to detect 
connectivity and topological issues in the stoichiometric matrix and flagging issues that might arise during constraint-
based optimization [16].  
In order to perform the in silico simulations and to predict the metabolic flux distribution under different conditions 
in S. clavuligerus cultures, flux balance analysis (FBA) was carried out, as described elsewhere [17]. 
Biomass composition 
The biomass composition of S. clavuligerus consisted of protein, DNA, RNA, lipids (phospholipids and 
triacylglycerol), cell wall constituents (peptidoglycan, carbohydrates, teichoic acid and trehalose), and small 
molecules. Defining the biomass equation is a crucial step to obtain high-quality models [18]; yet, there is not detailed 
information about biomass constituents of S. clavuligerus. The first GSMM for streptomycetes species was the iLB711 
model for S. coelicolor [6]; since then, biomass composition and equations for this species have been used for the 
related emerging models as for S. clavuligerus. 
Robustness analysis (RA) 
The effect of different substrate concentrations (C, N, P and O - sources) on biomass and antibiotic production (CA) 
was studied; the maximum consumption rate for each substrate was set to 1 mmol·gDW-1·h-1 and, for the prediction 
of different effects on the antibiotic biosynthesis rate, the growth rate was constrained to 90% of the maximum value 
so as to avoid the unrealistic case of CA production without biomass growth. The flux towards CA biosynthesis was 
maximized as the objective function. RA was performed to evaluate the phenotypic response (growth rate and CA 
production) to perturbations on the different substrates generally used in S. clavuligerus cultures. For this, an in silico 
minimal medium was used, GAPI, containing glycerol, ammonia and phosphate; all other exchange reactions were 
constrained to zero, except for oxygen, ions, water and hydrogen, which were left unconstrained. 
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Validation of the iLT1021 model and evaluation of alternative objective functions 
In this work, we used experimental data reported by Bushell et al. [19] for a continuous culture, as constraints to 
investigate the validity of the iLT1021 model. Different studies [20-23] consider growth rate maximization as the 
most appropriate objective function; however, this may not be the case for experimental instances such as the 
production of secondary metabolites e.g., antibiotics [24]. Therefore, additional experimental data sets, including 
batch cultures, were proposed as scenarios for the evaluation of different linear and non-linear objective functions 
(obfuncs). The obfuncs used in this study were: max Biomass, max ATP, max ATP/flux and max Biomass/flux 
(maximization of ATP and biomass yield per unit flux, respectively); these obfuncs have been reported for other 
microbial growth simulations [22]. Using all the experimental constraints, the prediction of every objective function 
was observed by the correlation of scatter plots of separated flux-by-flux comparisons, to see how each experimental 
flux distribution matches the corresponding predictions. To quantify the overall agreement, we used the similarity 
between the multiple computational and experimental results by means of the Euclidean distance criteria, as described 
elsewhere [21]. 
Essential gene analysis 
We analysed the essentiality of individual genes of S. clavuligerus under minimal (GAPI) and complex medium 
condition (CPX); the amino acid exchange reactions were set to 0.1 mmol·gDW-1·h-1 and genes were sequentially 
deleted one at the time. The genes were categorized in three classes: (i) essential - genes required for cellular growth; 
(ii) conditionally essential - considerable reduction of growth rate; and (iii) non-essential - genes not required for 
cellular growth. Simulations using FBA as well as the ‘grRatio’ function, (relative growth rate ratio), computed the 
growth rate ratio between the one obtained from the model with a deleted gene and the original model without 
deletions. ‘grRateWT’, represents the cell growth rate calculated using the original model (1/h) and the cell growth 
considering each knockout strain ‘grRateKO’ (cell growth rate calculated from the model with a reaction deletion/gene 
(1/h)). The essential gene analysis was conducted using the “singleGeneDeletion” function of the COBRA toolbox 
[11]: if the grRatio was lower than 10−6, the gene was defined as essential. The biomass growth rate was set as the 
objective function for the different simulations.  
Metabolic targets for increasing clavulanic acid production (strain design) 
The use of genome scale models has been widely adopted, not only to simulate cell growth but also to predict beneficial 
gene knockout/overexpression to improve the production of metabolites of interest [22]. One of the most recent 
approach for the in silico strain design, RoBoKoD (Robust, Overexpression, Knockout and Dampening), is able to 
optimize the target product considering simultaneously the cellular growth using a multi-objective problem [23]. The 
RoBoKoD method uses flux variability analysis (FVA) to profile each reaction under differing production percentages 
of target-compound and biomass synthesis [23]. Using these profiles, reactions were identified as potential knockout, 
overexpression or dampening targets; the later correspond to those less intuitive alternatives that were not considered, 
according to the RoBoKoD method [23]. RoBoKoD was implemented for strain design using the iLT1021 model to 
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identify the group of candidate genes to be altered (overexpressed/knocked-out), keeping those essential for cell 
growth and maintenance; as selection criteria, the rank of the reactions, overexpression (OER) or Knockout Ranking 
(KOR) > 0 were used. 
All calculations were made in MATLAB R2014a 8.3.0.5.32 (Mathworks Inc.; Natick, MA) utilizing the SMBL 
Toolbox [25], and the COBRA Toolbox [11].  LP and MILP problems were solved using the Gurobi Solver [26]. 
Results and discussion 
Reconstruction and properties of the model iLT1021 
The most remarkable feature of modelling S. clavuligerus is the large size of its genome, 8,556,892 base pairs (6.760 
Mb chromosome and 1.796 Mb plasmid), compared to typical bacterial genomes [8]. Regarding the annotation, 7281 
protein-coding genes were predicted as open reading frames (ORFs), including at least 1838 hypothetical proteins, 
1367 putative proteins, 6 rRNAs operons, 73 tRNAs and 48 secondary metabolite clusters. Only 1175 ORFs have an 
enzyme commission (E.C.) number assigned. 
For the purposes of metabolic model reconstruction, we considered all the metabolic pathways that have been reported 
as active/operative in S. clavuligerus, and also for which most of the pathway specific enzymes were present. The 
model included the biosynthesis of the b-lactam antibiotics CA and CephC. The biosynthetic route of clavams 5S and 
the last steps of the CA pathway are not yet completely elucidated [27]. Fig.1 presents the overall metabolic pathway 
content in terms of the percentage of total genes assigned to each pathway. 
[FIGURE 1] 
The updated genome scale model for S. clavuligerus was named iLT1021; it contains 1494 metabolic reactions (1295 
metabolic conversions and 199 transport reactions), 1360 metabolites and 1021 genes that account for 14 % of the 
total ORFs (see Table 1). Using the model SEED pipeline [10], a reconstructed/parallel draft model was obtained; it 
comprised 1358 reactions, 1470 metabolites and 1039 genes in order to obtain reaction-protein association 
automatically and include missing information in the final reconstruction project. The correct annotation was guided 
by checking correspondence to the PATRIC annotation [13] for the S. clavuligerus strain (prj:47867) and StrepDB 
database (http://strepdb.streptomyces.org.uk/). Finally, it was used as template to model GPR association. 
We revised and expanded the published model [8] to generate the iLT1021 model, integrating new features that 
represent the metabolic capabilities of S. clavuligerus. Initially, 16 exchange reactions without associated metabolites 
in the core (cytoplasm) were identified. The model rendered 10 dead-ends; 2 genes not registered in databases were 
missing in the original model and corrected. Notwithstanding the clavam biosynthetic pathway is not completely 
elucidated, hypothetical reactions and the associated genes (SCLAV2922, SCLAV2923, SCLAV2928 and 
SCLAV2803) were added to the model to enable simulation of 5S clavam biosynthesis [27]. The lack of information 
about cofactors and precursors and the absence of experimental data reported for the clavam pathway undoubtedly 
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restricts the work on simulation for this part of secondary metabolism. However, the integration of available 
information constitutes an important input for CA biosynthesis studies; hence it is possible to infer carbon flux at the 
CA bifurcation point, wherein flux splits to yield either CA or 5S clavams, and to establish stoichiometric ratios that 
might explain the metabolic fate of carbon. 
Further modifications included reactions for trehalose metabolism (SCLAV0623, SCLAV4349, SCLAV1446 and 
SCLAV3253) and most importantly, an updated biomass equation [28]. These changes in reactions/genes will become 
constraints for simulating S. clavuligerus metabolism, especially when integrating omics data e.g., transcriptomics or 
proteomics, to the model. The set of reactions, metabolites, and genes included in the model are provided in 
Supplementary material 1 and 2. 
A summary of the features of the constructed model is shown in Table 1, along with a comparison with the most 
recent high quality GSMMs for S. clavuligerus [8], and for S. coelicolor [24]. The addition of 157 genes to the iLT1021 
(most of them located in the chromosome) results in a considerable increase of ORF coverage, an important factor in 
the analysis of gene essentiality and strain design. The identified missing links were filled either by the introduction 
of sink reactions to allow for material exchange between the cell and its surrounding environment, or by including 
reactions from other phylogenetically related organisms. The MC3 software [16] was used to detect gaps and dead-
end metabolites. MC3 statistics did render a final model with 334 dead-end metabolites and 476 zero flux reactions 
(Supplementary material 1), showing that 70% of the reactions were active under the tested conditions; this might 
be explained by the inactivity of those transport reactions with no exchange of products or reactants, thus causing 
dead-ends. Dead-ends detected were involved neither in the biomass synthesis nor in the cellular metabolism. 
 
[TABLE 1] 
Biomass equation 
The biomass equation for S. clavuligerus was updated in the iLT1021 model; we used the macromolecular and 
monomeric composition of S clavuligerus [28]. Trehalose was included in the macromolecular composition in the 
updated iLT1021 model, as trehalose and glycogen are the two major forms of carbohydrate storage in actinomycetes 
[5]. The monomeric composition of biomass was calculated using S. avermitilis as a reference; this strain is genetically 
closer to S. clavuligerus than S. coelicolor (see Fig.2). The amino acid content was calculated from codon usage. The 
content of glycine (Gly), leucine (Leu), aspartate (Asp), threonine (Thr) and proline (Pro) was very different compared 
with the protein composition generally used for the S. coelicolor models. Finally, while the composition of most 
macromolecules was identical to that of model iIB711, protein, RNA, DNA and carbohydrate composition were quite 
different (see Supplementary material 1). 
[FIGURE 2] 
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Determination of energetic parameters 
For the calculation of energetic parameters for S. clavuligerus (i.e. the growth and non-growth associated ATP 
maintenance values, GAM and NGAM, respectively), we used available chemostat data obtained at four dilution rates 
[19]. As for microbial systems the P/O ratio (the number of ATP molecules formed per oxygen consumed during 
respiration) does not exceed 2.0 [24], the P/O ratio in our simulations was constrained to 1.75. Lastly, the NADH 
dehydrogenase complex flux ratio was constrained to 1:3 (reactions Rxn0631 and Rxn0633), as it was suggested for 
the iIB711 model. 
Using chemostat culture data from dilution rates in the range 0.02 to 0.07 h-1, we calculated the intercept and slope by 
linear regression (from a plot of the specific growth rate as a function of the specific glycerol uptake rate). The intercept 
for the specific glycerol uptake rate (x-axis) was 0.025 mmol glycerol·gDW-1·h-1. Using this value, a NGAM value of 
3.03 mmol ATP·gDW-1·h-1 was obtained by FBA, while maximizing ATP consumption rate. A GAM value of 48.5 
mmol ATP·gDW-1 was obtained by FBA with maximization of ATP as the objective function. These GAM and 
NGAM values are in good agreement to those reported for the S. coelicolor A3(2) models. For iMK1208, NGAM and 
GAM were 2.65 mmol ATP gDW-1·h-1 and 75.7 mmol ATP gDW-1, respectively, while for iIB711, these values were 
3.8 and 47.0, respectively [6,24]. The values calculated for GAM and NGAM were used to adjust the biomass and the 
ATP maintenance requirement reactions, respectively. 
In silico prediction of carbon and nitrogen utilization 
The S. clavuligerus capability of utilizing different carbon and nitrogen sources for growth was predicted by FBA. 
Each substrate carbon source was used as a sole carbon source in the in silico minimal medium, assuming uptake rates 
of 1.0 mmol·gDW−1 h−1. The simulation results were compared to experimental data, as shown in Table 2. A 93.5% 
match was obtained, which indicates that the S. clavuligerus model predicts the activity of the diverse pathways for 
catabolism of the different carbon and nitrogen sources. These results are in good agreement with experimental reports 
[29-31]. 
Since the model included a transport reaction for glucose as a sole carbon source, it did predict cellular growth. 
However, S. clavuligerus cannot grow on glucose due to a deficient expression of glucose permease (glcP) [32]. 
Clearly, despite the predictive power of GSMM, they possess inherent limitations related to the absence of regulatory 
issues in stoichiometric models. Furthermore, this linear modelling approach does not consider the topological and 
flux connectivity features, which are indeed non-linear. 
[TABLE 2] 
Robustness analysis 
We performed a RA to evaluate the response of growth and CA production towards perturbations on substrate uptake 
and antibiotic production rates. Fig. 3 shows the RA results for growth rate (Fig. 3a and Fig. 3b) and CA (Fig. 3c), 
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as objective functions. The effect of phosphate uptake on cell growth shows a maximum growth rate µ of 0.07 h-1 for 
a P flux of 0.15 mmol·gDW-1h-1. An increase in the flux of P promotes a decrease in growth rate down to zero at a P 
uptake rate of 1.0 mmol·gDW-1h-1. Varying the oxygen uptake rate, maximum growth rate was achieved at an oxygen 
uptake rate of 0.01 mmol·gDW-1·h-1. The growth rate remained constant at higher uptake rates. This is consistent with 
the obligate aerobic metabolism of S. clavuligerus for CA production. 
In the case of glycerol, simulations showed a linear behaviour for growth rate as a function of the C-source uptake 
rate over the range of uptake rates tested; no inflexion point was observed. Changes in the N-source uptake rate showed 
that maximal growth rate is observed at an optimal uptake rate of 0.58 mmol·gDW-1·h-1. Higher uptake rates (>0.6) 
caused a decrease in growth rate. 
Regarding secondary metabolism (Fig. 3b), both CA and CephC biosynthesis showed similar results. Metabolic 
simulations allow for the study of extreme scenarios. Cell growth and no antibiotic production provide a feasible 
scenario, while maximum antibiotic biosynthesis rates with no cell growth becomes biologically unfeasible. Between 
those extreme scenarios, the phenotypic space shows all feasible biomass and product pair combinations in steady 
state flux vectors, where low growth rates favour antibiotic production [3]. 
With the purpose of determining the influence of the different substrates on CA biosynthesis (Fig. 3c), the value of 
the growth rate was restricted to 90% of the optimum value to ensure a scenario of CA synthesis along with biomass, 
and avoid the extreme non-feasible scenario, i.e. CA production without growth. The P-source shows a negative effect 
on CA production at high uptake rates and favourable at limiting conditions, coinciding with the well-known 
experimental data for S. clavuligerus where the most favourable conditions for antibiotics biosynthesis are observed 
at suboptimal phosphate concentrations [34]. 
The C-source and oxygen had the same effect on antibiotic production as that observed for growth rate as objective 
function. Finally, the N-source showed a negative effect on CA production at uptake rates above 0.655 mmol·gDW-
1·h-1, with maximum values observed for uptake rates in the range 0.586 - 0.655 mmol·gDW-1·h-1. The negative effect 
of ammonia on CA production has been previously reported for in vivo studies; ammonia must be removed from the 
cells to avoid toxic intracellular concentrations that compromise growth [34]; the ammonia-free conditions also have 
been reported as favourable due to inhibitory and/or repressive effect of this nitrogen source [35]. 
[FIGURE 3] 
Simulation and validation of model iLT1021 
Available chemostat data of a phosphate-limited chemically defined media was used to run simulations [19]. In their 
studies, Bushell et al., [19] carried out chemostat cultures at four dilution rates; measured rates included glycerol and 
oxygen consumption, and CO2 and CA excretion. The results revealed that antibiotic yields decreased with the increase 
of growth rate (Supplementary Figure S1). The complete dataset is shown in Table 3. 
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[TABLE 3] 
Using cell growth as objective function, the in silico growth rates were closed to experimental values at low dilution 
rates (differences were 4.0 and 17% from the 0.03 and 0.05 h-1, respectively). However, at high growth rates (0.07 and 
0.1 h-1), the in silico values diverged from the in vivo values, while CO2 rate was low (see Table 3). This discrepancy 
might be caused by a limited respiratory capacity rather than due to the biomass equation; a similar phenomenon was 
observed using the iMK1208 model for S. coelicolor [24]. In this regard, authors concluded that model prediction 
made by conventional FBA cannot capture a phenomenon in which carbon waste occurs due to low respiratory 
efficiency at high dilution rates [24]. 
Simulations using biomass growth as objective function resulted in no CA production, since, as a secondary 
metabolite, the CA biosynthesis is not essential for growth and will compete for biosynthetic precursors (e.g 
glyceraldehyde-3-phosphate) and energetic resources. This result agrees with those shown for actinorhodin (ACT) 
production using the S. coelicolor iIB711 model [36]. 
Exploring different objective functions using the iLT1021 model to predict growth and antibiotic production 
The validation results showed that, using biomass maximization as objective function, the model could not predict the 
experimentally observed CA production pattern in chemostat cultures (Supplementary Figure S1). Therefore, 
additional experimental datasets were used for the evaluation of different linear and non-linear objective functions 
(obfuncs). Besides the P-limited chemostat data by Bushell et. al [19], we used data from P-limited continuous cultures 
at two different dilution rates [28], which included additional data for phosphate and ammonia uptake rates. We also 
used data from a batch culture using a defined media supplemented with glutamate and proline [33], which included 
the production rate of cephamycin C. With these datasets, the suitability of each objective function (Table 4) was 
tested. 
[TABLE 4] 
Objective functions were linear obfuncs (maximization of biomass and ATP yields), and non-linear maximization of 
ATP (max ATP/flux) and biomass yield per unit flux (max Biomass/flux) [21]. Supplementary Figure S2 shows a 
scatter plot for individual flux predictions contrasting predicted and experimental fluxes for all the objective functions 
evaluated. The dotted line represents the linear regression for correlation coefficient calculations. FBA studies have 
been previously used as a valuable tool for process design in antibiotic production, using maximization of cell growth 
as obfuncs [6,7,5]. Sánchez et al, [37] used CA production and ATP yield as obfuncs, as alternative functions to cell 
growth maximization [37]. In these simulations, using the experimental dataset from Bushell et al. [19] as constraints, 
the maximization of ATP yield showed to be the best predictor of cellular behaviour [19].  
 
The correlation between the experimental fluxes reported and those predicted by the iLT1021 model are presented in 
Fig S2.a. In these simulations, maximization of ATP yield renders the highest correlation coefficients (0.81 to 0.85), 
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followed by maximization of biomass per flux unit (0.74 to 0.79) and maximization of biomass yield (0.40 to 0.48). 
The same behaviour was observed using a different continuous culture data set [28] (Fig S2.b), though higher 
correlation coefficients were attained, R=0.86 and R=0.81-0.82 for max ATP and max biomass/flux respectively; this 
is due to the cellular objective being strongly dependent on the input data, in this case a larger dataset. Finally, batch 
culture data (Fig S2.c) showed a very good correlation by maximizing biomass yield (R = 0.99) and maximization of 
ATP yield per flux unit (R = 0.99). Maximization of ATP yield and biomass per flux unit also showed a high R 
coefficient. These results agree with previous reports [20, 21, 36, 38], which supported the maximization of biomass 
as the objective function for FBA in batch cultures [21]; in contrast, chemostat cultures were better predicted by the 
ATP yield maximization. Overall, the two non-linear objective functions seem to be reliable for the cases tested. 
Although some objective functions provided reasonable predictions under the conditions evaluated, there is no 
consensus about which one has to be used when studying secondary metabolism. Therefore, special care should be 
taken in the evaluation and analysis of objective functions, case by case for each particular condition.  
Identification of essential genes  
The gene essentiality analysis revealed that 12.73% and 10.01% of total genes in iLT1021 are essential for cell growth 
in minimal (GAPI) and complex media (CPX), respectively (see Fig. 4). A total of 100 genes were essential in both 
conditions and an additional group of 30 genes were essential only in minimal media (see Fig. 4). Genes participating 
in central metabolism SCLAV3951 (fructose-1,6-bisphosphatase II), SCLAV1142 (glucose-6-phosphate isomerase), 
SCLAV2648 (fructose-bisphosphate aldolase), SCLAV3252 (trehalose-6-phosphate synthase) and SCLAV3630, a 
gene coding for DNA-directed RNA polymerase subunit beta essential for growth (transcription process), were 
essential in both the GAPI and the CPX medium conditions. 
In order to identify genes essential for cell viability under each condition, a functional categorization was made. We 
identified the distribution of genes across different metabolic processes. Aminoacyl-tRNA biosynthesis shows the 
most lethal genes (20%), since all genes involved are used for the synthesis of biomass precursors, mainly for protein 
macromolecules [39], for amino acid biosynthesis (16.90%) and purine metabolism (11.53%). For the CPX medium, 
supplemented with amino acids, nutrients were directly up taken and metabolized, therefore maintaining various 
biosynthetic pathways inactive; genes associated with these pathways were classified as non-essential. However, 
certain amino acid pathways were identified as essential for cell maintenance and growth, such as the biosynthetic 
pathways of phenylalanine, tyrosine and tryptophan. The amino acid associated gene argininosuccinate synthase 
(SCLAV0796) is involved in the arginine biosynthetic pathway [40], essential for both growth and secondary 
metabolism. Argininosuccinate synthase seems to be involved in the developmental changes observed in the bacterial 
life cycle, as its disruption prevents the formation of aerial mycelium in several Streptomyces strains [41]. 
In a previous S. clavuligerus model [8], which used the same minimal media (GAPI) for validation purposes, a total 
of 100 essential genes were identified and the knockouts applied to the enzyme-coding genes located in the 1.8Mb 
pSL4 plasmid did not show any effect on growth. This suggests that the mega-plasmid does not encode any functions 
essential to primary metabolism. Interestingly, gene essentiality analysis using the iLT1021 model reported, for the 
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minimal media, 30 additional essential genes, which were added in the early reconstruction steps. Most of them belong 
to multi-copies in the chromosome except SCLAVp0971, which is located in the pSL4 plasmid, encoding for 3-
dehydroquinate synthase [EC:4.2.3.4]. This reaction is part of the shikimate pathway, involved in the biosynthesis of 
aromatic amino acids such as phenylalanine, tyrosine, and tryptophan. 
[FIGURE 4] 
Strain design for clavulanic acid overproduction 
A total of 316 reactions were identified as potential targets for overexpression, with an overexpression ranking (OER) 
greater than zero, suggesting that 35.4 % of the total genes would be worthy of being explored so as to acquire 
clavulanic acid overproduction. The higher OER value was 1.182 for the N-glycyl-clavaminic acid synthetase (gcas) 
and clavaldehyde dehydrogenase (cad); these reactions are involved in the CA biosynthetic pathway (see Table 5 and 
Supplementary material 1). The gene gcas represents the first identified biosynthetic intermediate of the pathway 
that is specific only for clavulanic acid and not for 5S clavams; meanwhile, cad reduces the clavaldehyde intermediate 
to clavulanic acid (last step) [42]. A second group of the CA biosynthetic genes, involved in the early steps, ceas1/2, 
bls1/2 and pah1/2 had an OER of 0.9733. The overexpression of the structural biosynthetic genes ceas2, bls2, cas2 
and pah2 resulted in an 8.7-fold increase in CA titers [43]. 
Moreover, pyruvate dehydrogenase and malonate-semialdehyde dehydrogenase (OER: 0.8621), isocitrate 
dehydrogenase (IDH) NADP+ (OER: 0.8414) and histidinol-phosphate aminotransferase (OER: 0.8492) seem to be 
targets for further genetic engineering studies, since its overexpression results in higher pools of acetyl-coA and/or 
alpha-ketoglutarate, the latter a co-substrate in clavaminic acid biosynthesis. IDH (NADP+) is an important target of 
the TCA pathway as it increases NADPH availability, a cofactor in the conversion of clavaminic acid to CA. Also, 
the selected reactions favour the biosynthesis of ornithine from glutamate, an essential amino acid precursor of CA 
via arginine [5]. 
Glycerol can be metabolized through glycerol dehydrogenase, aldehyde dehydrogenase and glycerate kinase to form 
2-phosphoglycerate and subsequently pyruvate [28]. The knock-out analysis suggested that glycerate-kinase, with a 
knock out ranking (KOR) of 0.7001, might be modified so as to favour the anaplerotic pathway towards the 
glyceraldehyde-3-phosphate pool, thus reducing amino acid biosynthesis via oxaloacetate and pyruvate, allowing 
glycerol dehydrogenase and aldehyde dehydrogenase to increase the C3 precursor pool for clavulanic acid 
biosynthesis. Concerning amino acid metabolism, SCLAV2394 gene codes for L-aspartate oxidase; its knockout 
might avoid the formation of iminoaspartate thus allowing aspartate to be used as precursor in the synthesis of arginine, 
the C5 CA precursor. Likewise, by knocking-out glycolate oxidase (KOR: 1.058) and isocitrate lyase (KOR: 0.6930), 
we could infer that blocking the respective reactions the flux through the glyoxylate shunt decreases, allowing the 
synthesis of aspartate and alpha-ketoglutarate, key precursors in CA biosynthesis, since malate and isocitrate are not 
compromised in alternative routes. 
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Finally, although the reactions concerning the synthesis of clavams were included in the model, the lack of information 
about cofactors and even reactants within the clavam pathway prevented the use of RoBoKoD [23]; accordingly, the 
analysis did not render such reactions as potential targets. Even though RoBoKoD has not been validated beyond E 
coli for butanol [23] and tryptophan [44] production, it proved to be a useful tool for strain design through accurate 
prediction of favourable genetic interventions; therefore, it would be of great interest to validate the predictions 
presented here for S. clavuligerus.  To our knowledge, in silico tools for the metabolic design of S. clavuligerus strains 
have not been explored in depth, beyond the approach presented here. 
[TABLE 5] 
Conclusions 
In this work, an expanded genome-scale metabolic model of S. clavuligerus, iLT1021, was reconstructed and updated 
with an amended biomass equation and the introduction of clavam biosynthesis and trehalose metabolism. The 
developed model was validated by growth capabilities and robustness analysis; model predictions were in agreement 
with reported experimental data. 
In constraint-based analysis of secondary metabolism in Streptomyces, the choice of an appropriate objective function 
is a key step to describe the metabolic shift from exponential to stationary growth phase. This study also reports on 
the analysis of different objective functions to predict the biomass growth along with CA biosynthesis using the 
iLT1021 model. Our results revealed that ATP yield is the best objective function to maximize in order to obtain a 
reliable model. 
RoBoKoD was used along with the iLT1021 model to perform a strain design to overproduce clavulanic acid; this 
analysis identified a group of genes that have not been explored experimentally in overexpression / knockout analysis, 
especially genes located in the CA gene cluster. Moreover, this study also advises about new potential targets for 
metabolic engineering; among others, the IDH, glyK and NAD+ synthase (glutamine-hydrolysing) genes were 
identified. These results encourage the continuous development of GSMM as potential tools for bioprocess 
optimization. 
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Table 1 Comparison of Streptomyces-species genome and model characteristics 
 
Genome features 
 S. clavuligerus S. coelicolor A3(2) 
Sequence length 8.556 Mb 8.667 Mb 
G+C content 72% 72% 
Total open reading frames 7281 7825 
in silico model features 
 iLT1021 Medema’s model [8] iMK1208 [24] 
Number of reactions 1494 1492 1643 
Number of genes 1021 864 1208 
Transport reactions 199 202 216 
ORF associated to reactions    
(% Total reactions) 66 58 86 
ORF coverage (%) 14 11 15 
Metabolites 1360 1375 1246 
Compartments 2 (c, e) 2 (c, e)            2(c, e) 
 
 
 
 
 
Table 2 Simulation of Growth for alternative carbon sources 
Carbon Source  Nitrogen Source 
Substrate Growth Ref.  Substrate Growth Ref. 
Acetate + [29]  L-arginine + [29,31] 
Citrate + [29]  L-alanine + [29] 
Fumarate + [29]  L-asparagine + [29] 
Glycerol + [29]  L-aspartate + [29] 
D-ribose + [29]  L-glutamate + [29,31] 
L-lactate + [29]  L-glutamine + [29] 
L-malate + [29]  L-isoleucine + [29] 
Maltose + [29]  L-leucine + [29] 
Pyruvate + [29]  L-lysine + [29] 
Succinate + [29]  L-methionine - [29] 
Sucrose + [33]  L-phenylalanine + [29] 
D-Glucose - (iLT1021: +) [29, 30]  L-proline + [29] 
Trehalose    (iLT1021: +) This study  L-valine + [29] 
α-ketoglutarate + [29]  L-threonine + [29]    
 L-ornithine + [31] 
    Ammonia + [33] 
    Urea + [33] 
(+) Growth; (-) no growth.  
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Table 3 Comparison of in silico and in vivo growth rates of S. clavuligerus 
 
Media condition 
 (mmol·gDW-1 ·h-1) 
Growth rate 
 (h-1) 
            CO2  
(mmol·gDW-1· h-1) 
Glycerol  O2 in vivoa in silicob in vivo in silico 
4.88 12.81 0.03 0.0313 6.41 8.86 
6.51 15.56 0.05 0.0585 13.42 11.81 
10.09 19.68 0.07 0.0836 14.86 13.63 
23.67 53.43 0.1 0.188 66.52 37.04 
aexperimental results taken from Bushell et al [19]; bsimulation results. 
 
 
 
 
Table 4 Objective functions evaluated using the iLT1021 model 
 
Objective Function Description Mathematical Definition 
max Biomass Maximization of biomass yield. max !"#$%&''!()*+,-$) 
max ATP Maximization of ATP yield. max !./0!()*+,-$) 
max ATP/flux Maximization of ATP yield per flux unit max !./0∑ !#2  
max Biomass/flux Maximization of biomass per flux unit. max !"#$%&''∑ !#2  
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Table 5 Reactions selected as potential targets for overexpression/knockout so as to increase CA biosynthesis  
 
Overexpression 
Reaction ID Reaction name Gene               association Ranking Ref. 
Rxn0967 N-glycyl-clavaminic acid synthetase (gcas) SCLAV4181 1.1825 This study Rxn0968 Clavaldehyde dehydrogenase  (cad) [EC: 1.1.1.100] SCLAV4190 
Rxn0961 N2-(2-carboxyethyl) arginine synthase (ceas) [EC:2.5.1.66] SCLAV4197 SCLAVp1074 
0.9733 [43]  
Rxn0962 Carboxyethyl-arginine beta-lactam-synthase (bls) [EC:6.3.3.4] SCLAV4196 
Rxn0963 
Rxn0965 
Rxn0966 
Clavaminate synthase 1 or 2 (cas) [EC:1.14.11.21] SCLAV2925  SCLAV4194 
Rxn0964 Proclavaminate amidinohydrolase (pah) [EC:3.5.3.11] SCLAV4195 
Rxn0675 Pyruvate dehydrogenase [EC: 1.2.4.1 ] SCLAV1613 0.8621 [5] 
Rxn0097 Isocitrate dehydrogenase (NADP+) [ EC: 1.1.1.42 ] SCLAV0808 0.8414 
This 
study Rxn0849 Malonate-semialdehyde dehydrogenase [ EC: 1.2.1.18] 
SCLAV1899 
SCLAVp0939 0.8621 
Rxn0207 Histidinol-phosphate aminotransferase [EC: 2.6.1.9] SCLAV1261 0.8492 
Knock-out 
Reaction ID Reaction name Gene            association Ranking Ref. 
Rxn0138 Glycolate oxidase [EC:1.1.3.15] SCLAV2040 1.058824 
This 
Study 
Rxn0324 NAD+ synthase (glutamine-hydrolysing) [EC:6.3.5.1] SCLAV1480 0.857143 
Rxn0320 L-aspartate oxidase [EC:1.4.3.16] SCLAV2394 0.857143 
Rxn0001 Glycerate kinase [EC:2.7.1.31] SCLAV0632 SCLAV0878 0.70010 
Rxn0135 Isocitrate lyase [EC:4.1.3.1] SCLAVp0927 0.693038 
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